A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killing
Hwang JK., Marston DJ., Wrapp D., Li D., Tuyishime M., Brackenridge S., Rhodes B., Quastel M., Kapingidza AB., Gater J., Harner A., Wang Y., Rountree W., Ferrari G., Borrow P., McMichael AJ., Gillespie GM., Haynes BF., Azoitei ML.